You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
HIV ANTIGEN & ANTIBODY SCREEN W/ CONFIRMATION |
||
Geisinger Epic Procedure Code: LAB2467
Geisinger Epic ID: 45912
|
||
SPECIMEN COLLECTION |
||
Specimen type: |
Serum | |
Preferred collection container: |
||
Specimen required: |
1 mL serum; minimum 1 mL | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Allow to clot. Centrifuge to separate serum within 2 hours of collection. | |
Transport temperature: |
Refrigerated (preferred). | |
Specimen stability: |
Room temperature: 7 days. Refrigerated(2 - 8°C): 4 weeks. Frozen: 3 months. No more than 5 freeze/thaw cycles. | |
Rejection criteria: |
Specimen will be rejected if stability limit is exceeded or if specimen is hemolyzed or icteric. Add-ons available only to unopened tube. | |
TEST DETAILS |
||
Reference interval: |
Negative. | |
Interpretation guide: |
CDC Recommended Laboratory HIV Testing | |
CPT code(s): |
87389 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Qualitative detection of antibodies to human immunodeficiency virus type 1 and type 2. Positive result will be reflexed to "HIV1/HIV2 antibody differentiation assay. | |
Methodology: |
Electrochemiluminescence Immunoassay |
|
Synonyms: |
HIV-1/HIV-2 ANTIBODY;HIV antibody combo, HIV GEN 4 HIV4G
|
|
Clinical significance: |
HIV Ag/Ab Combo assay is an immunoassay for the simultaneous qualitative determination of human immunodeficiency virus (HIV) p24 antigen and antibodies to HIV type 1(HIV-1 group M and group O) and/or type 2 (HIV-2). Specimens with a reactive HIV AG/AB Combo assay result should be tested with a confirmatory assay that differentiates HIV-1 from HIV-2 antibodies. | |
Doctoral Director(s:) |
Hoi-Ying Elsie Yu, PhD, DABCC, FADLM Sheng-Ying (Margaret) Lo, PhD, DABCC |
|
| Review Date: | 12/14/2022 | |